Investigation of usefulness of molecular functional imaging to observe vascular remodeling and tumor oxygenation of breast cancer after start of eribulin mesylate

Investigation of usefulness of molecular functional imaging to observe vascular remodeling and tumor oxygenation of breast cancer after start of eribulin mesylate - functional imaging to observe vascular remodeling and tumor oxygenation of breast cancer after eribulin mesylate

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015839

Enrollment

Registered

2014-12-03

Start date

2014-12-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unresectable locally advanced or metastatic breast cancer patients which need chemotherapy

Interventions

Diffuse optical spectroscopy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who get informed consents on paper Patients with 20 year old or more Patients who had unresectable locally advanced (T4 or N2) or metastatic breast cancer Patients who already recieved anthracycline and taxane chemotherapy

Exclusion criteria

Exclusion criteria: Patients whom doctor consider the treatment is suitable for Patients who have uncontroled infection Patients who had severe AEs prior to chemotherapy

Design outcomes

Primary

Measure	Time frame
Effect of tissue oxygenation of breast cancer tumors to erubulin	—

Countries

Japan

Contacts

Public ContactShigeto UEDA

Saitama International Medical Center Department of breast oncology

syueda@saitama-med.ac.jp81-42-984-4670

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026